Durgical
EN
Open the app

Fibroids: who needs treatment and which

  • Disorder

Most women with fibroids never need treatment. Where the fibroid sits decides what it does, and what it does decides the treatment.

Updated

See it in 3D: Body of uterus · Fundus of uterus · Cervix · Uterine artery · Urinary bladder

What it is

Uterine fibroids (leiomyomas) are benign, oestrogen- and progesterone-sensitive tumours of the myometrium, found in a large share of women by age 50 and more common and larger in women of African descent. Most cause no symptoms. When they do, the problems are heavy menstrual bleeding with iron-deficiency anaemia, pressure (urinary frequency, constipation, a mass) and, for fibroids that distort the cavity, subfertility and miscarriage. The FIGO system types them 0 to 8 by their relation to the endometrium and serosa. Treatment depends on symptoms, the fibroid's type and size, age, and whether she wants to keep her uterus or become pregnant.

How to recognise it

  • Heavy, prolonged periods with an enlarged, irregular, firm, non-tender uterus.
  • Pressure: urinary frequency, retention, constipation, a palpable mass.
  • Ultrasound (transvaginal plus abdominal) confirms them; saline sonography or hysteroscopy maps submucosal ones; MRI before complex surgery or embolisation.
  • FIGO 0 pedunculated in the cavity, 1 less than half in the wall, 2 half or more in the wall, 3 touching the lining but fully in the wall, 4 intramural, 5 and 6 subserosal (more or less than half in the wall), 7 pedunculated subserosal, 8 other sites such as the cervix.
  • Fibroids grow with oestrogen and progesterone and usually shrink after menopause.

Matching the treatment to the woman and the fibroid

OptionBest forKeeps fertility?Main limits
Watchful waitingNo symptoms, any size; near menopauseYesUltrasound follow-up if growing
Tranexamic acid, NSAIDs, hormonal methods, levonorgestrel IUDHeavy bleeding with little cavity distortionYes (contraceptive while used)Do not shrink fibroids; IUD may be expelled with a distorted cavity
GnRH agonist or antagonist (with add-back hormones for longer use)Shrinking before surgery, bridging to menopauseYes (not while used)Menopausal symptoms and bone loss; regrowth after stopping
Hysteroscopic myomectomySubmucosal fibroids (types 0, 1, some 2)YesNot for intramural or subserosal fibroids
Laparoscopic or open myomectomySymptomatic intramural or subserosal fibroids in a woman who wants her uterusYesBleeding, adhesions, recurrence; uterine scar to consider in labour
Uterine artery embolisationSymptomatic fibroids, wants to avoid surgeryUncertainPain after the procedure; not first choice if pregnancy is planned
HysterectomyFamily complete, other options failed or not wantedNoMajor surgery; the only definitive cure

Differential and risks

  • Chain of harm: submucosal fibroid → larger, distorted endometrial surface and impaired contraction around it → heavy bleeding → iron loss → iron-deficiency anaemia.
  • Differential: adenomyosis (diffusely enlarged, tender, globular uterus, more pain), pregnancy (always test), endometrial polyp or cancer (bleeding after 45 or with risk factors needs endometrial sampling), ovarian mass (separate from the uterus on ultrasound).
  • Rapid growth after menopause, or a fibroid that grows while she is on suppression, raises concern for leiomyosarcoma: refer to gynaecological oncology.
  • In pregnancy fibroids may cause pain from degeneration, malpresentation, obstructed labour and postpartum haemorrhage.
  • Acute pain with fever may be degeneration or torsion of a pedunculated fibroid.
  • Fibroids in pregnancy: most change little and cause no trouble. Red (carneous) degeneration, usually in the second trimester, gives acute pain and tenderness over the fibroid, sometimes with low fever and a raised white count; it settles within days with rest and analgesia (paracetamol, opioids if needed; NSAIDs are avoided in the second half of pregnancy) once abruption and other causes are excluded. Large or lower-segment fibroids raise malpresentation, obstructed labour, caesarean and postpartum haemorrhage from poor uterine contraction; removing fibroids at caesarean is generally avoided because of bleeding.
  • Fibroids and infertility: submucosal fibroids (types 0 to 2) distort the cavity, lower implantation and raise miscarriage, and hysteroscopic removal improves the chance of pregnancy; large intramural fibroids may matter; subserosal fibroids do not affect fertility and are left alone.
  • Uterine fibroid embolisation, how it works: an interventional radiologist blocks both uterine arteries, or the branches feeding the fibroids, with small particles under X-ray guidance → the fibroids lose their blood supply and undergo ischaemic necrosis → they shrink, and bleeding and pressure ease. A minority of fibroids are also fed by other arteries, which can limit the result.
  • Who it suits and outcomes: symptomatic fibroids in a woman who wants to avoid surgery and is not planning pregnancy. In trials, satisfaction at two to five years was similar to surgery, with a shorter stay, faster return to activities and fewer transfusions, but more minor complications and more repeat procedures: about 15 to 32% need further surgery within two years, against about 7% after surgery.
  • Fertility caveat: it is not the method of choice for women planning pregnancy. In a systematic review, pregnancies after embolisation had lower live birth and higher miscarriage rates than after myomectomy; concerns include loss of ovarian function, abnormal placental attachment and growth restriction.
  • Post-embolisation syndrome: in the first hours to days, pelvic pain from ischaemia of the fibroids and the normal myometrium, with nausea, vomiting, low-grade fever, tiredness and a raised white count. It is common (almost half of women in one series had a clinically significant form) and is treated with analgesia, including anti-inflammatory drugs; vaginal discharge can follow too.

Next step / Initial management

  • Check haemoglobin and iron stores in heavy bleeding, and treat iron deficiency.
  • Pregnancy test; endometrial sampling when bleeding is irregular or risk factors for endometrial cancer exist.
  • No symptoms: reassure and do not treat; repeat ultrasound only if symptoms appear or the uterus grows.
  • Symptoms: start with medical treatment of bleeding; refer for surgery or embolisation when it fails, the cavity is distorted, there is subfertility or pressure, or anaemia persists.
  • Refer urgently for acute severe bleeding, urinary retention, or suspected sarcoma.

Common traps

  • Every fibroid seen on ultrasound needs treatment: most are asymptomatic and need only reassurance.
  • A small fibroid cannot explain heavy bleeding or subfertility: a small submucosal (type 0 to 2) fibroid can cause both, because location matters more than size.
  • A levonorgestrel IUD or GnRH treatment will remove the fibroids: the IUD controls bleeding but does not shrink them, and GnRH-induced shrinkage reverses after stopping.
  • Any fibroid can be removed through the hysteroscope: only cavity-based (submucosal) fibroids can; intramural and subserosal ones need laparoscopy or laparotomy.
  • Every fibroid should be removed before fertility treatment: only cavity-distorting (submucosal) fibroids clearly lower fertility; subserosal ones do not, and surgery adds adhesions and a uterine scar.
  • Embolisation is the uterus-sparing choice for a woman who wants to conceive soon: myomectomy gives better pregnancy outcomes, and embolisation is not the method of choice when pregnancy is planned.

Test yourself

Think of the answer, then tap the question to see it.

A 41-year-old with a 3-centimetre subserosal fibroid found on a routine scan has normal periods and no symptoms. What do you advise?

No treatment: an asymptomatic fibroid needs only reassurance and review if symptoms appear.

Why can a 1-centimetre submucosal fibroid cause heavier bleeding than a 6-centimetre subserosal one?

The submucosal fibroid distorts the endometrial surface and the uterine contraction that controls bleeding, while a subserosal fibroid sits under the serosa, away from the lining.

A 34-year-old with infertility has a type 0 fibroid. Which treatment fits?

Hysteroscopic myomectomy: the fibroid is inside the cavity and can be removed through the cervix, preserving the uterus.

A 62-year-old has a uterine mass that has grown quickly since the last scan. What must be considered?

Leiomyosarcoma: fibroids normally shrink after menopause, so growth needs urgent gynaecological oncology referral.

At 18 weeks a woman with a known 7-centimetre fibroid has sudden pain and tenderness over it and a low fever. What is the likely cause and management?

Red degeneration, as the fibroid outgrows its blood supply. After excluding abruption and other causes, rest and analgesia (paracetamol, opioids if needed); it settles within days.

Add to my cards (5)

Elsewhere in DurgiPedia

Connections

← All of obstetrics and gynaecology

Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.

Sources: Uterine Leiomyomata (StatPearls (NCBI Bookshelf), 2025); Uterine Fibroid Embolization (StatPearls (NCBI Bookshelf), 2025); Adenomyosis (StatPearls (NCBI Bookshelf), 2026); Fertility Sparing Management in Uterine Fibroids (StatPearls Publishing (NCBI Bookshelf), 2023); Uterine artery embolization for symptomatic uterine fibroids (Cochrane Database of Systematic Reviews (Gupta JK et al.), PubMed 25541260, 2014); Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids (Reproductive BioMedicine Online (Khaw SC et al.), PubMed 32081542, 2020); Currently Available Treatment Modalities for Uterine Fibroids (Medicina (Kaunas), 2024); The Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in the Management of the Post-Embolization Symptoms after Uterine Artery Embolization (Pharmaceuticals (Basel), 2010); PREDICTing Post-Embolization Syndrome after uterine fibroid embolization: the PREDICT-PES study (British Journal of Radiology (Clements W et al.), PubMed 39969955, 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.